Home » News
The INFRAPLUS’s kick-off took place over two productive days in Munich. With lively discussions and concrete plans, we have set the stage for INFRAFRONTIER’s expansion in state-of-the-art in vivo models, innovative in vitro models, preclinical services, and data analysis. All set to get started!
Our partners from Biocenter Oulu have co-authored a study revealing that two TIE1 loss-of-function variants are linked to primary lymphedema, a condition causing tissue swelling and fibrosis, and are lethal in homozygous mice.
The Finnish EMMA node, in collaboration with the University of Oulu, successfully concluded a practical Tissue Analysis Course for doctoral students. Delving into disease modelling and digital pathology, among other topics, participants gained invaluable insights and resources to enhance their research carrier.
The visit of Dr. Yoshitaka Fujihara marks the successful startup of the Fibrobesity Visitor Programme launched by our partner in Finland, the University of Oulu. In this way, Dr. Fujihara has become the first visiting professor supported by the mentioned programme. The 2-weeks stay took place last October thanks to the hospitality of Dr. Renata Prunskaite-Hyyryläinen’s laboratory.
Under the canSERV Open Call, researchers are invited to apply for a portfolio of services covering the entire oncology developmental pipeline, with the participation of 9 INFRAFRONTIER partners providing in vivo services. Deadline: 4 January 2023
A new publication of INFRAFRONTIER in Mammalian Genome is available on line now. Get an overview of the latest INFRAFRONTIER advancements, including services, resources, and technical developments.
Staff from Oulu EMMA node and Oulu Laboratory Animal Centre visited the axenic and gnotobiology facilities at Instituto Gulbenkian de Ciência (IGC), Lisbon.
As part of the ERN-ITHACA network actions, partners from the Children’s Memorial Health Institute in Warsaw, visited Oulu University Hospital and University of Oulu in Finland. The guests received a series of trainings on molecular genetic methods.
The 17th Transgenic Technology Meeting (TT2022), organized by the International Society of Transgenic Technology (ISTT) will take place on 17 – 20 September 2022 in Helsinki, Finland.
A new multi-organ disease named FINCA (Fibrosis, Neurodegeneration and Cerebral Angiomatosis) that is fatal in early childhood has been identified in three pediatric patients in Finland. Children affected have previously undescribed formation of connective tissue in the lungs, neurodegeneration and increased vasculature formation in the brain.
In a formal act authenticated by a notary in Munich, four founding members acquired shares of the INFRAFRONTIER GmbH: the Centre National de la Recherche Scientifique (CNRS) from France, the Biomedical Sciences Research Center ‘Alexander Fleming’ from Greece, the Institute of Molecular Genetics of the Acedemy of Sciences of the Czech Republic, and the University of Oulu in Finland.
